BMI OrganBank

About:

BMI OrganBank develops medical devices and perfusion technology to improve organ and tissue preservation for transplantation.

Website: https://bmiorganbank.com

Top Investors: National Institutes of Health

Description:

BMI OrganBank develops innovative medical devices and perfusion technology to enhance organ and tissue preservation for transplantation. The company collaborates with academic institutions to expand the possibilities of organ transplantation and improve patient outcomes. BMI OrganBank focuses on creating solutions that could transform kidney transplantation and other organ preservation methods, benefiting thousands of patients in need of transplants.

Total Funding Amount:

$3.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Winston Salem, North Carolina, United States

Founded Date:

2005-01-01

Contact Email:

hello(AT)bmiorganbank.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2024-11-19

IPO Status:

Private

Industries:

© 2025 bioDAO.ai